Trial Profile
Controlled, nonrandomized clinical research on chemotherapy combined with re-endostatin for stage IIB osteosarcoma
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 01 Sep 2015
Price :
$35
*
At a glance
- Drugs Endostatin (Primary) ; Cisplatin; Doxorubicin; Ifosfamide; Methotrexate
- Indications Osteosarcoma
- Focus Therapeutic Use
- 01 Sep 2015 New trial record